Piper Sandler analyst Rob Owens raised the firm’s price target on Varonis (VRNS) to $55 from $48 and keeps a Neutral rating on the shares. The firm notes Q3 results surpassed expectations across both ARR and free cash flow, though guidance lacked the follow-through to this momentum that many had hoped for, with Q4 NNARR implying a steep deceleration in growth.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.